Retina Eye Center

11/13/2025

We’re proud to have Dr. Demediuk on our team, bringing years of experience and a reputation for thorough, compassionate care. Patients trust her expertise, and we’re honored to be part of their journey.

11/11/2025

To all veterans, thank you for your service, your strength, and your sacrifice. We are deeply grateful for your service.

11/06/2025

November is National Diabetes Month, a timely reminder that diabetic retinopathy is the leading cause of blindness in adults aged 20 to 74. High blood sugar over time can damage the retina’s blood vessels, leading to vision loss if not managed early. Regular eye exams and proper diabetes care are critical to protecting your sight. Learn more: https://brnw.ch/21wXgXL

10/30/2025

Looking to learn more about retinal health and eye care? We’ve gathered trusted resources from leading ophthalmic organizations to help support your journey. Learn more: https://brnw.ch/21wX4Tf

10/28/2025

Beacon Therapeutics has announced encouraging results from two phase 2 trials of laru-zova, a gene therapy for X-linked retinitis pigmentosa (XLRP), a rare inherited condition that often leads to blindness. Learn more about the results found: https://brnw.ch/21wX031

In both trials, Beacon’s lead program, laru-zova, was found to be well-tolerated by SKYLINE participants through month 36 and DAWN patients at month 9 or longer.

10/23/2025

Dr. Ranjit Dhaliwal is a board-certified ophthalmologist and vitreoretinal surgeon with decades of experience treating complex retinal diseases. With advanced training from Johns Hopkins and Washington University, and faculty roles at Queen’s University and Emory, he combines academic excellence with compassionate patient care right here in Augusta. Learn more: https://brnw.ch/21wWT0I

10/21/2025

A recent study found that individuals with age-related macular degeneration may have a higher risk of heart-related health issues, especially if they already have cardiovascular risk factors. Even early signs of AMD were linked to an increased likelihood of heart-related outcomes. Learn more: https://brnw.ch/21wWNR0

The presence of AMD predicted an increased risk of all-cause and CVD mortality in patients with a high risk of CVD, even in the early stages of AMD.

10/16/2025

Age-related macular degeneration is the leading cause of vision loss in adults over 50, and it affects the part of the eye responsible for sharp, central vision. Early detection, regular monitoring, and timely treatment can help preserve vision. Learn more: https://brnw.ch/21wWGIV

10/14/2025

Belite Bio has completed a phase 3 clinical trial for tinlarebant, a potential first-ever treatment for Stargardt disease, a rare inherited form of vision loss. This oral medication aims to slow damage to the retina by reducing harmful vitamin A byproducts. Results are expected in late 2025. Learn more: https://brnw.ch/21wWBH5

Belite Bio completes its phase 3 trial for tinlarebant, a potential first treatment for Stargardt disease, with results expected in late 2025.

10/09/2025

We’re honored to be part of stories like this. Helping patients protect and preserve their vision over the years is exactly why we do what we do.

10/07/2025

A recent study found that pregnant women with type 1 diabetes are not at higher risk of developing sight-threatening diabetic retinopathy compared to nonpregnant women with the same condition. This is reassuring news for expecting mothers managing diabetes and eye health. Learn more: https://brnw.ch/21wWpTr

A study reveals similar risks of sight-threatening diabetic retinopathy in pregnant women with type 1 diabetes compared to nonpregnant controls.

10/02/2025

Preparing for retinal surgery? Knowing what to expect after your procedure can make recovery smoother and less stressful. From common surgeries like vitrectomy to essential post-op tips, our blog breaks it all down so you can feel confident and informed. Learn more: https://brnw.ch/21wWiSz